Smarteeva ESG NextGen Integration - Direct MDR Submission to FDA Through the New API

Smarteeva Now Submits Medical Device Reports Directly to FDA Through the ESG NextGen API

What is the ESG NextGen integration?

Smarteeva’s ESG NextGen integration is a direct API connection between the Smarteeva platform and the FDA’s new Electronic Submissions Gateway. Regulatory teams complete an MDR inside Smarteeva’s complaint and adverse event workflow and submit it to the FDA from the same screen. The API handles formatting, transmission, and validation in the background. There is no separate step.

FDA acknowledgement messages return through the API and appear directly in Smarteeva’s submission tracker. Teams can see whether a report was accepted, rejected, or pending without checking a separate system. If a submission fails validation, Smarteeva identifies the specific fields that need correction and lets teams fix and resubmit in minutes, not hours.

This is not a file-upload workaround built on top of the new gateway. It is a system-to-system API connection that removes the manual packaging and portal-hopping the old gateway required.

‍

Why ESG NextGen matters for medical device companies

The legacy Electronic Submissions Gateway was built for a regulatory environment with far less data volume and far lower expectations for speed. As complaint volumes grow and regulatory timelines tighten globally, the old infrastructure had become a bottleneck.

ESG NextGen addresses this with three changes that directly affect MedTech companies.

The old gateway required manual file packaging. Regulatory teams had to export MDR data from their quality system, package it as XML, upload it through a separate portal, and wait for an asynchronous acknowledgement that could take hours or days. If validation failed, the entire process had to restart from scratch.

The new gateway is API-first. It was designed for system-to-system communication, not manual uploads. This allows platforms like Smarteeva to embed FDA submission into existing workflows rather than treating it as a separate process.

ESG NextGen also uses updated authentication and encryption standards, reducing compliance risk at the transmission layer. And for companies that file thousands of MDRs annually, the new gateway handles volume without the throughput limitations and peak-period backlogs that plagued the old system.

‍

What changes for Smarteeva clients

The ESG NextGen integration changes three things about how Smarteeva clients submit MDRs to the FDA.

Submission happens inside the platform

Before ESG NextGen, submitting an MDR to the FDA involved packaging XML files, uploading them through the legacy gateway, and waiting. With the API integration, regulatory teams complete the MDR in Smarteeva and submit it from the same screen. The API handles formatting, transmission, and validation in the background.

Acknowledgements arrive in real time

FDA acknowledgement messages return through the API and appear directly in Smarteeva’s submission tracker. Teams see whether a report was accepted, rejected, or pending without logging into a separate system. This eliminates the lag and the manual cross-referencing that the legacy gateway required.

Resubmission friction disappears

Under the old system, validation failures meant repackaging files and resubmitting from scratch. With the API, Smarteeva identifies the specific fields that need correction and lets teams fix and resubmit in minutes, not hours. The process stays inside the platform from start to finish.

How the integration works

The technical flow is straightforward. When a regulatory team member completes an MDR in Smarteeva and clicks submit, the platform performs four steps in the background.

Step 1: Format. Smarteeva converts the MDR record into the format required by the ESG NextGen API, including all required field mappings and validation rules.

Step 2: Transmit. The API sends the formatted submission directly to the FDA’s ESG NextGen endpoint over an encrypted connection using updated authentication protocols.

Step 3: Validate. The FDA’s system runs its validation checks and returns a response. If the submission passes, an acceptance acknowledgement appears in Smarteeva’s tracker. If it fails, the specific fields that need correction are flagged inside the platform.

Step 4: Track. The submission status, acknowledgement messages, and any follow-up actions are logged in Smarteeva’s submission history. The entire lifecycle of the MDR, from creation to FDA acceptance, is visible in one place.

The team never leaves Smarteeva. There is no separate portal, no file export, and no manual step between completing the report and submitting it.

‍

Security and compliance

ESG NextGen uses updated authentication and encryption standards. Smarteeva’s integration connects through these protocols without exposing complaint data to intermediate systems. Adverse event reports often contain protected health information. The API connection ensures that data moves directly from Smarteeva’s platform to the FDA’s infrastructure without passing through a third-party upload portal.

All submission activity is logged in Smarteeva’s audit trail: the submission timestamp, the API response, the acknowledgement status, and any resubmission history. This gives regulatory teams a complete, auditable record of every MDR filed through the platform.

‍Closing

Smarteeva already processes 35% of all FDA Medical Device Reports and manages 1 in 5 FDA recalls. The ESG NextGen integration removes the last manual step in that workflow. For clients filing thousands of MDRs per year, this means faster submissions, real-time confirmation, and no more resubmission bottlenecks caused by the legacy gateway.